| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,348 |
22,765 |
$1.76M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,854 |
11,897 |
$739K |
| Q3014 |
Telehealth originating site facility fee |
17,262 |
14,223 |
$389K |
| 99407 |
|
7,432 |
6,868 |
$258K |
| 90837 |
Psychotherapy, 53 minutes with patient |
2,364 |
1,433 |
$214K |
| 99442 |
|
4,797 |
4,310 |
$131K |
| 99443 |
|
4,921 |
4,344 |
$111K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
2,246 |
2,105 |
$88K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,832 |
1,737 |
$76K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,166 |
1,834 |
$70K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,320 |
1,249 |
$47K |
| 90834 |
Psychotherapy, 45 minutes with patient |
783 |
532 |
$46K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
442 |
412 |
$42K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
859 |
802 |
$35K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
958 |
816 |
$34K |
| 90791 |
Psychiatric diagnostic evaluation |
323 |
227 |
$21K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
293 |
271 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
684 |
568 |
$19K |
| 99401 |
|
294 |
280 |
$7K |
| 99441 |
|
382 |
340 |
$6K |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
73 |
70 |
$5K |
| G0180 |
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
219 |
212 |
$3K |
| 90832 |
Psychotherapy, 30 minutes with patient |
60 |
46 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
79 |
73 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
41 |
40 |
$2K |
| 90658 |
|
16 |
16 |
$1K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
36 |
33 |
$986.51 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
38 |
16 |
$423.20 |
| 99406 |
|
37 |
35 |
$389.75 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
21 |
13 |
$285.68 |
| 98968 |
|
15 |
15 |
$204.61 |
| 80306 |
|
19 |
19 |
$138.87 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
474 |
403 |
$91.35 |
| 97803 |
|
18 |
17 |
$90.44 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
73 |
61 |
$90.14 |
| 99000 |
|
51 |
44 |
$0.00 |